Advocacy intelligence hub — real-time data for patient organizations
Institut Pasteur — NA
ANRS, Emerging Infectious Diseases — NA
Institut Pasteur — NA
South Australian Health and Medical Research Institute — PHASE4
Oregon Health and Science University — PHASE1, PHASE2
Ministry of Public Health, Argentina — NA
Sanofi Pasteur, a Sanofi Company — PHASE2
Sanofi Pasteur, a Sanofi Company — PHASE2
University of Aarhus — PHASE4
Oswaldo Cruz Foundation — PHASE4
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Reinaldo M Martins, PhD
Oswaldo Cruz Foundation
Odile LAUNAY
CIC Cochin Paris
Ed Clarke, MD
Medical Research Council Unit, The Gambia
Sophie MATHERON
Maladies Infectieuses et Tropicales Bichat Paris
Eduardo Sergio S Sousa, MD
Universidade Federal da Paraíba
Timothy Schacker, MD, MD
University of Minnesota
📍 MINNEAPOLIS, MN